Natural Product: NPC598498

Natural Product IDNPC598498
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2,3-dihydroxypropyl hexadeca-9,12-dienoate
IUPAC Name 2,3-dihydroxypropyl hexadeca-9,12-dienoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000175] Glycerolipids
        • [CHEMONTID:0003808] Monoradylglycerols
          • [CHEMONTID:0001133] Monoacylglycerols
            • [CHEMONTID:0001597] 1-monoacylglycerols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey UYILNCYYYVUPEC-UHFFFAOYSA-N
Standard InCHI InChI=1S/C19H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)23-17-18(21)16-20/h4-5,7-8,18,20-21H,2-3,6,9-17H2,1H3
SMILES CCCC=CCC=CCCCCCCCC(=O)OCC(O)CO

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   326.25 Volume:   364.432
?
Van der Waals volume.
Dense:   0.895 LogP:   4.136
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.296
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.544
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   16.0 Rigid Bonds:   3.0
TPSA:   66.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.272 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.021 Fsp3:   0.737
MCE-18:   2.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.028 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.919 Promiscuous compounds:   0.044

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.057 MDCK Permeability:   -4.879
Pgp-inhibitor:   0.0 Pgp-substrate:   0.094
PAMPA:   0.342
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.133
20% Bioavailability (F20%):   0.476 30% Bioavailability (F30%):   0.692
50% Bioavailability (F50%):   0.822

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.098 MRP1:   0.926
Plasma Protein Binding (PPB):   97.371% Volume Distribution (VD):   -0.375
Fu: 3.168%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.031
OATP1B3 inhibitor:   0.872 BCRP inhibitor:   0.133
BSEP inhibitor:   0.77

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.622
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.984 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.835 CYP2D6-substrate:   0.997
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.997
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.407
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.652 Half-life (T1/2):  0.504

ADMET: Toxicity

hERG Blockers:  0.067 hERG Blockers (10um):  0.394
Human Hepatotoxicity (H-HT):  0.104 Drug-induced Liver Injury (DILI):  0.001
AMES Toxicity:  0.616 Rat Oral Acute Toxicity:  0.009
Maximum Recommended Daily Dose:  0.019 Skin Sensitization:  1.0
Carcinogencity:  0.259 Eye Corrosion:  0.629
Eye Irritation:  0.938 Respiratory Toxicity:  0.043
Drug-induced Neurotoxicity:  0.016 Ototoxicity:  0.691
Hematotoxicity:  0.011 Drug-induced Nephrotoxicity:  0.349
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.024
A549 Cytotoxicity:  0.061 Hek293 Cytotoxicity:  0.021
BCF:   1.649
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.681
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.062
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.909
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a The rural area of Viçosa, State of Minas Gerais (MG), Brazil Adult stage PMID[35282307]
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28907 Sonchus arvensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC598498 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9444 High Similarity NPC330426
0.9444 High Similarity NPC127091
0.9444 High Similarity NPC22101
0.8919 High Similarity NPC271921
0.8649 High Similarity NPC321919
0.8611 High Similarity NPC104537
0.7692 Intermediate Similarity NPC475443
0.7692 Intermediate Similarity NPC473829
0.725 Intermediate Similarity NPC476654
0.725 Intermediate Similarity NPC476655
0.725 Intermediate Similarity NPC476656
0.7073 Intermediate Similarity NPC209327
0.6944 Remote Similarity NPC488257
0.6944 Remote Similarity NPC469937
0.6944 Remote Similarity NPC94699
0.6944 Remote Similarity NPC320588
0.6944 Remote Similarity NPC53463
0.6923 Remote Similarity NPC277597
0.6905 Remote Similarity NPC273508
0.6842 Remote Similarity NPC28779
0.6667 Remote Similarity NPC473559
0.6667 Remote Similarity NPC324981
0.6591 Remote Similarity NPC473772
0.641 Remote Similarity NPC10316
0.641 Remote Similarity NPC200845
0.625 Remote Similarity NPC474321
0.6136 Remote Similarity NPC54925
0.6053 Remote Similarity NPC128061
0.6 Remote Similarity NPC48218
0.6 Remote Similarity NPC141481
0.6 Remote Similarity NPC464342
0.6 Remote Similarity NPC609455
0.5926 Remote Similarity NPC489083
0.5897 Remote Similarity NPC39633
0.561 Remote Similarity NPC223677
0.5517 Remote Similarity NPC21693
0.55 Remote Similarity NPC139545
0.5455 Remote Similarity NPC81896
0.5385 Remote Similarity NPC26253
0.5349 Remote Similarity NPC148192
0.5333 Remote Similarity NPC110813
0.5333 Remote Similarity NPC39290
0.5254 Remote Similarity NPC236649
0.5227 Remote Similarity NPC485026
0.5128 Remote Similarity NPC309606
0.5122 Remote Similarity NPC71761

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC598498 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.55 Remote Similarity NPD5343 Phase 4
0.5435 Remote Similarity NPD3728 Approved
0.5238 Remote Similarity NPD6096 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data